Better Dividend Stock: Pfizer vs. GSK
Better Dividend Stock: Pfizer vs. GSK Yahoo Finance
Covered in this story
Analyst targets on Pfizer
- Cantor Fitzgerald: $28.3 → $28 by Oct 2027 · Neutral via TIKR.com
- Bank of America: $28.3 → $29 by Oct 2027 · Neutral via TIKR.com
- JPMorgan: $28.3 → $30 by Oct 2027 · Neutral via The Globe and Mail
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PFE yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Pfizer →Also covered by 1 other outlet
- Better High-Yield Dividend Stock: Pfizer vs. Healthpeak
- Better High-Yield Dividend Stock: Pfizer vs. UPS
Dalsna Finance is currently tracking 48 stories mentioning Pfizer, the earliest published 18 Jun 2026.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.